semaglutide launch date Canada approves generic from Dr. Reddy's, a G7 first enabled by Novo Nordisk's lapsed CAD$250 patent Generic Ozempic 2026: Release Date

Mol Neurobiol 53(10):69977009

A recent clinical trial concluded that diabetic patients lost an Trusted Source A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight (SURMOUNT-2) Eli Lilly and Company Go to Source average of 15.7% of their body weight (averaging 34.4 pounds) when taking the highest dose of Mounjaro for 72 weeks

[PubMed] [Google Scholar] Hareter A

Semaglutide is not recommended during breastfeeding due to insufficient safety data in lactating women

Local Expertise in Cincinnati, Ohio Diabetes Doctors in Cincinnati, Ohio are well-versed in the local healthcare landscape

As more is learned about GLP-1 receptor agonists like semaglutide, nurses will remain a vital link in helping patients understand, manage, and thrive on their treatment journey